Literature DB >> 23807646

NF-κB and systemic lupus erythematosus: examining the link.

Adeel Zubair1, Marianne Frieri.   

Abstract

Physicians should be knowledgeable regarding several aspects of autoimmune disorders, especially systemic lupus erythematosus (SLE), with which patients can present in their office with urticaria or vasculitis and which may masquerade as another condition. This paper reviews the link between NF-κB and SLE, including B-cell development, signaling and cytokines which play a crucial role in the pathogenesis of SLE and T-cell development, a key player in T-cell activation. The roles of dendritic cells, which can promote tolerance or immunity to antigens, of polymorphisms and of NF-κB, which are linked with SLE, are also discussed. The role of Toll-like receptors which are important in the pathogenesis of SLE and lupus nephritis is also discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807646     DOI: 10.5301/jn.5000272

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  10 in total

1.  HDAC expression and activity is upregulated in diseased lupus-prone mice.

Authors:  Nicole L Regna; Miranda D Vieson; Alexander M Gojmerac; Xin M Luo; David L Caudell; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2015-10-21       Impact factor: 4.932

Review 2.  B cell biology: an overview.

Authors:  Hermann Eibel; Helene Kraus; Heiko Sic; Anne-Kathrin Kienzler; Marta Rizzi
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

3.  Small Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus.

Authors:  Tonika Lam; Dennis V Kulp; Rui Wang; Zheng Lou; Julia Taylor; Carlos E Rivera; Hui Yan; Qi Zhang; Zhonghua Wang; Hong Zan; Dmitri N Ivanov; Guangming Zhong; Paolo Casali; Zhenming Xu
Journal:  J Immunol       Date:  2016-10-14       Impact factor: 5.422

4.  Precision Targeting of NF-κB Signaling in Lupus Nephritis.

Authors:  Dawn J Caster; David W Powell
Journal:  Lupus (Los Angel)       Date:  2020-12-28

Review 5.  Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis.

Authors:  Marianne Frieri; William Heuser; Joshua Bliss
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun

6.  Review: Immunology of sinusitis, trauma, asthma, and sepsis.

Authors:  Marianne Frieri; Krishan Kumar; Anthony Boutin
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

7.  The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response.

Authors:  Leon Louis Seifert; Clara Si; Debjani Saha; Mohammad Sadic; Maren de Vries; Sarah Ballentine; Aaron Briley; Guojun Wang; Ana M Valero-Jimenez; Adil Mohamed; Uwe Schaefer; Hong M Moulton; Adolfo García-Sastre; Shashank Tripathi; Brad R Rosenberg; Meike Dittmann
Journal:  PLoS Pathog       Date:  2019-11-04       Impact factor: 6.823

8.  Ubiquitin Activating Enzyme UBA6 Regulates Th1 and Tc1 Cell Differentiation.

Authors:  Ji Yeon Lee; Eun-Koung An; Juyoung Hwang; Jun-O Jin; Peter C W Lee
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

9.  Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.

Authors:  Yohan Seo; Chin Hee Mun; So-Hyeon Park; Dongkyu Jeon; Su Jeong Kim; Taejun Yoon; Eunhee Ko; Sungwoo Jo; Yong-Beom Park; Wan Namkung; Sang-Won Lee
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

Review 10.  Circadian rhythms and renal pathophysiology.

Authors:  Rajesh Mohandas; Lauren G Douma; Yogesh Scindia; Michelle L Gumz
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.